Sep 2nd, 2018 – Cheli Gonnen is joining Silenseed as Vice President of Clinical Affairs. Gonnen will lead the company’s clinical development including the Phase 2 study (NCT01676259, now recruiting) in Locally Advanced Pancreatic Cancer (LAPC). Cheli is highly experienced in managing clinical trials in pharmaceutical and medical device companies. She brings to Silenseed her in-depth knowledge of all aspects of clinical trials at all stages. Previously Cheli served as the Clinical Trial Manager at OCON Medical Ltd., and at TCA Clinical Research. Before that Cheli served for about a decade as a Senior CRA in Merck Sharp & Dohme (MSD), covering phases I-IV in oncology and additional multiple therapeutic areas. Cheli received her M.Sc. in Biochemistry and Nutrition from the Hebrew University.